tasimelteon
VP-VEC-162-4201
Phase 1 small_molecule completed
Quick answer
tasimelteon for Circadian Rhythm Sleep Disorders is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Circadian Rhythm Sleep Disorders
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed